Thyroid Neoplasms Flashcards
The majority of solitary nodules of the thyroid are what?
Either benign adenomas or localized neoplastic conditions
Carcinomas only account for <1% of solitary thyroid nodules
Clinical criteria for thyroid nodules
Solitary nodules are more commonly neoplastic than multiple
Nodules in very young or old (<20; >70) are more likely to be neoplastic
Nodules in males are more likely neoplastic
History of radiation exposure increases risk of thyroid malignancy
Nodules that uptake radioactive iodine in imaging studies are more likely to be benign
What is the most definitive way to determine thyroid nodules characteristics
Meddle aspiration and staining
Adenomas of the thyroid
Benign neoplasms that are derived from follicular epithelium
Usually are solitary and clinically are difficult to distinguish from dominant nodules
Most are nonfunctional however if they do, they always produce thyrotoxicosis via “toxic adenoma”
Adenoma pathogenesis
Results from driver mutations in the TSH Rc pathway (results in toxic adenomas)
Also mutations in either:
1) TSH receptor itself (more likely)
2) a-subunit of GNAS protein (less likely)
Minority of non functioning follicular adenomas also exhibit mutations in RAS proteins (20%)
Gross Morphology of benign and neoplastic adenomas
Often can look similar however usually
- benign = solitary spherical lesions with less capsule present
- neoplastic = ell-defined intact capsules
the hallmark morphological appearance of an adenoma is a well-formed capsule encircling the tumor
Clinical features of adenomas
Most are painless growths with large masses
Thyrotoxicosis is often present as well as dysphagia if the growth is large enough
Radioactive iodine and adenomas
Most adenomas take up iodine less than normal thyroid tissue
- termed “cold nodules”
- roughly 10% become malignant if untreated
However toxic adenomas take up iodine more than normal thyroid tissue
- termed “hot nodules”
- less than 1% become malignant if untreated
What techniques are used in preoperative evaluation of suspected adenomas?
Ultrasound and fine needle aspiration
Definitive diagnosis require microscopic evaluation for a capsule
- then is pathogenomic
Thyroid carcinomas (CA)
More common in females
All except medullary CAs are derived from the thyroid follicular epithelium and vast majority are well-differentiated lesions
Major subtypes:
- papillary carcinoma (>85% of cases)
- follicular carcinoma (5-15%)
- medullary carcinoma (5%)
- anaplastic carcinoma (<5%)
Broad Thyroid carcinoma pathogenesis
Two pathways down streams from the growth factor receptors
1) RAS/BRAF/MAP kinase pathway
2) PI-3K/AKT pathway
Produces gain-of-function mutations in either or both of these pathways
What is the most common genetic feature of papillary carcinomas
MAP kinase mutations Which do one of two things:
1) rearrangements in genes that encode the receptor tyrosine kinases RET/NTRK1
2) Activating point mutations in BRAF
What is the most common genetic feature of follicular thyroid carcinomas
Both of the following:
1) Gain of function mutation in PI3K
2) Loss of function mutation in PTEN
What is a very unique genetic abnormality seen only in follicular thyroid carcinomas
33-50% of follicular carcinomas possess a unique t(2;3) translocation that disrupts PAX8
- PAX8 is a homebox gene that is important for TH development in thyroid gland follicles
Also shows Peroxisome Proliferator Activated Receptor Gene (PPARG) gene mutations
- is a nuclear hormone receptor that is required for terminal differentiation of cells
Anaplastic carcinomas
Aggressive tumors that can arise de novo but more commonly develop from progression of papillary or follicular carcinomas
Have all the follicular and papillary gene mutations but also present with
- loss of function in TP53